Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 16 November 2010, the interest of Simon Lowth, a Director of the Company, in AstraZeneca ordinary shares, changed as detailed below. The change in interest relates to the vesting of a previously announced award made in November 2007 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, Mr Lowth has now become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.
Name of Director |
Gross Shares Awarded |
Shares Lapsed |
Shares Vested |
Shares Withheld |
Net Shares Received |
Market Price on Vesting |
Simon Lowth |
15,554 |
3,422 |
12,132 |
6,188 |
5,944 |
3016p |
As a result of these transactions, Mr Lowth now has an interest in 201,070 AstraZeneca ordinary shares, which represents approximately 0.01% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
17 November 2010